133 related articles for article (PubMed ID: 30892436)
21. Mirabegron the first β3-adrenoceptor agonist for overactive bladder (OAB): a summary of the phase III studies.
Chapple C
BJU Int; 2014 Jun; 113(6):847-8. PubMed ID: 24905658
[No Abstract] [Full Text] [Related]
22. UPLC-MS/MS method for determination of avicularin in rat plasma and its application to a pharmacokinetic study.
Zhang WM; Li RF; Sun M; Hu DM; Qiu JF; Yan YH
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Aug; 965():107-11. PubMed ID: 25010713
[TBL] [Abstract][Full Text] [Related]
23. Determination of acacetin in rat plasma by UPLC-MS/MS and its application to a pharmacokinetic study.
Fan LH; Li X; Chen DY; Zhang N; Wang Y; Shan Y; Hu Y; Xu RA; Jin J; Ge RS
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Apr; 986-987():18-22. PubMed ID: 25703948
[TBL] [Abstract][Full Text] [Related]
24. Mirabegron: a safety review.
Tyagi P; Tyagi V; Chancellor M
Expert Opin Drug Saf; 2011 Mar; 10(2):287-94. PubMed ID: 21142693
[TBL] [Abstract][Full Text] [Related]
25. Validated UPLC-MS/MS method for determination of hordenine in rat plasma and its application to pharmacokinetic study.
Ma J; Wang S; Huang X; Geng P; Wen C; Zhou Y; Yu L; Wang X
J Pharm Biomed Anal; 2015; 111():131-7. PubMed ID: 25880244
[TBL] [Abstract][Full Text] [Related]
26. UPLC-MS/MS determination and gender-related pharmacokinetic study of five active ingredients in rat plasma after oral administration of Eucommia cortex extract.
Hu F; An J; Li W; Zhang Z; Chen W; Wang C; Wang Z
J Ethnopharmacol; 2015 Jul; 169():145-55. PubMed ID: 25910535
[TBL] [Abstract][Full Text] [Related]
27. Phase III Study to Assess Long-Term (52-Week) Safety and Efficacy of Mirabegron, a β
Yamaguchi O; Ikeda Y; Ohkawa S
Low Urin Tract Symptoms; 2017 Jan; 9(1):38-45. PubMed ID: 28120446
[TBL] [Abstract][Full Text] [Related]
28. Determination and validation of hupehenine in rat plasma by UPLC-MS/MS and its application to pharmacokinetic study.
Wen C; Wang S; Huang X; Liu Z; Lin Y; Yang S; Ma J; Zhou Y; Wang X
Biomed Chromatogr; 2015 Dec; 29(12):1805-10. PubMed ID: 26033449
[TBL] [Abstract][Full Text] [Related]
29. Determination of kurarinone in rat plasma by UPLC-MS/MS.
Zhang WM; Li RF; Qiu JF; Zhang ZY; Wang HB; Bian L; Lei JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Apr; 986-987():31-4. PubMed ID: 25703950
[TBL] [Abstract][Full Text] [Related]
30. Effects of mirabegron, a novel β3-adrenoceptor agonist, on primary bladder afferent activity and bladder microcontractions in rats compared with the effects of oxybutynin.
Aizawa N; Homma Y; Igawa Y
Eur Urol; 2012 Dec; 62(6):1165-73. PubMed ID: 22981677
[TBL] [Abstract][Full Text] [Related]
31. Simultaneous Determination of Bosentan, Glimepiride, HYBOS and M1 in Rat Plasma by UPLC-MS-MS and its Application to Pharmacokinetic Study.
Chen M; Song W; Wang S; Chen Q; Pan P; Xu T; Hu G; Zheng Z
J Chromatogr Sci; 2016 Aug; 54(7):1159-65. PubMed ID: 27240565
[TBL] [Abstract][Full Text] [Related]
32. Determination of rivaroxaban, apixaban and edoxaban in rat plasma by UPLC-MS/MS method.
Zhang WL; Lou D; Zhang DT; Zhang Y; Huang HJ
J Thromb Thrombolysis; 2016 Aug; 42(2):205-11. PubMed ID: 27116356
[TBL] [Abstract][Full Text] [Related]
33. Determination of parthenolide in rat plasma by UPLC-MS/MS and its application to a pharmacokinetic study.
Zhao AQ; Zhao JH; Zhang SQ; Pan YY; Huo XL
J Pharm Biomed Anal; 2016 Feb; 119():99-103. PubMed ID: 26678176
[TBL] [Abstract][Full Text] [Related]
34. A rapid and sensitive UPLC-MS/MS method for determination of HZ08 in rat plasma and tissues: application to a pharmacokinetic study of liposome injections.
Yan F; Sun M; Hang T; Sun J; Zhou X; Deng X; Ge L; Qian H; Ya D; Huang W
J Pharm Biomed Anal; 2015 Jan; 102():246-52. PubMed ID: 25305722
[TBL] [Abstract][Full Text] [Related]
35. Mirabegron, A Selective β3-Adrenoceptor Agonist Causes an Improvement in Erectile Dysfunction in Diabetic Rats.
Yilmaz-Oral D; Kaya-Sezginer E; Askin D; Hamurtekin Y; Gur S
Exp Clin Endocrinol Diabetes; 2021 Mar; 129(4):296-302. PubMed ID: 30978726
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetic study of ardisiacrispin A in rat plasma after intravenous administration by UPLC-MS/MS.
Fang B; Bao S; Wang S; Chen M; Chen B; Su K; Wen C; Zhou Y; Wang X; Jin Y
Biomed Chromatogr; 2017 Mar; 31(3):. PubMed ID: 27565758
[TBL] [Abstract][Full Text] [Related]
37. Determination of cephalomannine in rat plasma by gradient elution UPLC-MS/MS method.
Wang XS; Sun JC; Yang RN; Ren J; Liang S; Sun M; Wang YF; Gao SG
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jul; 963():70-4. PubMed ID: 24929960
[TBL] [Abstract][Full Text] [Related]
38. An HPLC-MS/MS method for simultaneous determination of the active metabolites of febuxostat (67M-1, 67M-2 and 67M-4) in human plasma.
Xie H; Wang Z; Deng K; Jiang X; Wang L; Lv G
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Nov; 970():24-30. PubMed ID: 25222745
[TBL] [Abstract][Full Text] [Related]
39. An Exploratory Study in Healthy Male Subjects of the Mechanism of Mirabegron-Induced Cardiovascular Effects.
van Gelderen M; Stölzel M; Meijer J; Kerbusch V; Collins C; Korstanje C
J Clin Pharmacol; 2017 Dec; 57(12):1534-1544. PubMed ID: 28618007
[TBL] [Abstract][Full Text] [Related]
40. Protective effect of a β3-adrenoceptor agonist on bladder function in a rat model of chronic bladder ischemia.
Sawada N; Nomiya M; Hood B; Koslov D; Zarifpour M; Andersson KE
Eur Urol; 2013 Oct; 64(4):664-71. PubMed ID: 23838637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
